2 enrolling by invitation. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Enrolling by invitation 2 |
Follow Asthma: new trials by email Literature Review of Asthma trials Research Report on Asthma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Efficacy and Safety of HSK31858 Tablets in Patients with Bronchial Asthma HSK31858, Placebo - Bronchial Asthma | Phase 2 | Enrolling by invitation | Haisco Pharmaceutical Group Co., Ltd. | 219 | 2024-10-22 | 2024-12-24 |
| Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Asthma Lunsekimig - Asthma | Phase 2 | Enrolling by invitation | Sanofi | 900 | 2024-09-30 | 2026-09-21 |
Bronchial Diseases (2) · Hypersensitivity (2) · Hypersensitivity, Immediate (2) · Immune System Diseases (2) · Lung Diseases (2) · Lung Diseases, Obstructive (2) · Respiratory Hypersensitivity (2) · Respiratory Tract Diseases (2)
Haisco Pharmaceutical Group Co., Ltd. (1) · Sanofi (1)
China (2) · Argentina (1) · Brazil (1) · Canada (1) · Chile (1) · Germany (1) · Hungary (1) · India (1) · Israel (1) · Italy (1) · Japan (1) · Mexico (1) · Poland (1) · South Africa (1) · South Korea (1)
2025 (1)